SCHEMBL845708

SCHEMBL845708

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3cccnc3Cl)cc2)cc1)[C@@H]1CCCN1C(=O)c1cccnc1Cl

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RHOC P08134 1/20 0.46
RHOA P61586 1/20 0.46
MAPT P10636 4/20 0.46
ALDH1A1 P00352 3/20 0.46
RAB9A P51151 1/20 0.46
HTT P42858 2/20 0.44
TRPV1 Q8NER1 1/20 0.43
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
ITGB1 P05556 2/20 0.41
ITGA4 P13612 2/20 0.41
EP300 Q09472 1/20 0.41
CREBBP Q92793 1/20 0.41
PABPC1 P11940 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845686 0.95 HSD11B1 (0.43) RHOCRHOAMAPTALDH1A1RAB9A
SCHEMBL844980 0.88 ALDH1A1 (0.45) RHOCRHOAMAPTALDH1A1HTT
SCHEMBL845710 0.85 KMT2A (0.43) MAPTALDH1A1RAB9AHTTTRPV1
SCHEMBL845301 0.84 PABPC1 (0.51) ALDH1A1HTTTRPV1CYP2C9CYP2C19
SCHEMBL845059 0.83 ALDH1A1 (0.46) ALDH1A1HTTTRPV1CYP2C9CYP2C19
SCHEMBL845442 0.82 CYP2C9 (0.43) RHOCRHOAMAPTALDH1A1HTT
SCHEMBL845048 0.82 DGAT1 (0.50) RHOCRHOAMAPTALDH1A1RAB9A
SCHEMBL845008 0.82 ALDH1A1 (0.54) MAPTALDH1A1HTTCYP2C9CYP2C19
SCHEMBL845651 0.82 CYP2C9 (0.43) RHOCRHOAALDH1A1HTTTRPV1
SCHEMBL845697 0.82 ALDH1A1 (0.45) RHOCRHOAMAPTALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed